Eli Lilly Didn’t Just Sue over Retatrutide. It Went After the Money.

When Eli Lilly filed six lawsuits over retatrutide, the headlines went to the courtroom. But Lilly did something the same day that matters more for anyone in this business. It went after the money.

Alongside the suits, Lilly publicly asked credit card companies, payment processors, and shipping carriers to cut off the sellers. It also flagged more than 200 businesses to regulators and reported over 14,000 websites and listings. The lawsuits are the slow part. The money move is the fast one.

Why is that relevant? A lawsuit takes years. A payment processor can drop you in days. I’ll say it now and I’ll say it again, if the revenue stops the company stops. The ability to process payments predicts whether a seller survives better than any FDA letter or court case. Vendors who lost their card processing tend to disappear within weeks. The more difficult pill to swallow is that most payment processors take an all or nothing approach. They are not going to shut down processing for just retatrutide, they will shut down payment processing across all products offered.

So let me explain how the money moves, because once you see it, the risk is obvious.

When a customer pays you with a card, the money doesn’t go straight to your bank. It runs through a payment processor. The processor is the middleman that moves the money from the customer’s card into your account. No processor, no card payments. It’s that simple. Businesses in risky categories get sorted into a bucket called “high-risk.” Peptide sellers land there fast. High-risk accounts cost more, the fees run higher, and the processor often holds back a chunk of your sales in something called a reserve.

A reserve works like this. The processor keeps, say, ten percent of everything you sell and sits on it for months. It’s their cushion in case customers demand refunds later. So, a piece of the money you earned isn’t in your hands; it’s parked with the processor.

Now picture Lilly’s letter landing on that processor’s desk. The processor sees legal risk and reputation risk. Card networks have their own rules against processing illegal goods. The safe and easy move for the processor is to cut the seller loose.

That means a business can look healthy on Monday and be gone by Friday. Can you just switch to another processor? Sometimes, for a while. But word travels. Once you’re flagged, the next processor asks questions, and the one after that says no. This is what people mean when they call the money pipes the real battlefield.

Here’s the lesson for any owner, in this space or any risky one. Your payment processor is a dependency you don’t control. If a single processor handles all your card sales and it drops you, your whole business runs on someone else’s decision. That’s called concentration risk, and it’s one of the most dangerous setups a business can have. The fix isn’t glamorous. Spread the risk. Keep more cash on hand than feels comfortable. Know exactly how much of your money sits in reserves and when you would get it back. Don’t let one processor become your only door to revenue.

If you’re the customer, this is why the vendor you bought your peptides from can vanish overnight. You send money on Tuesday. On Wednesday the seller loses its processor. Now they can’t take new orders, they can’t easily send refunds, and the money you paid may be tied up or gone. Your one tool is a chargeback, where you ask your card company to reverse the charge. It sometimes works, but there’s a time limit, and it’s a fight. The cheaper, faster option online often comes with no safety net at all.

Lilly knows all of this. Going after the money pipes isn’t a side move. It’s the main event, because it works faster than any judge. The first article in my series about the Eli Lilly lawsuit explained why this case has no legal gray area. This one shows how Eli Lilly is turning up the heat. The last piece steps back to ask the bigger question. Is this a one-time fight, or a playbook other drugmakers will run again and again?

Melissa Diaz, CPA

Founding Partner, High Rock Accounting

High Rock helps operators in complex, high-scrutiny industries build books that hold up. Questions about your exposure? highrock.co/contact